Anti-Human p34cdc2 Serine/Threonine Kinase - DyLight® 650
Anti-Human p34cdc2 Serine/Threonine Kinase - DyLight® 650 (P316-GRP)
Products
Description
p34cdc2 is thought to be activated by cyclin through dephosphorylation at tyrosine residues. Activated p34cdc2 kinase is involved in a number of mitotic events such as nuclear envelope breakdown and chromosome condensation through phosphorylation of serine/threonine residues of substrates such as nuclear lamins, histones, pp60c-src, nucleolin and RNA polymerase II. It is then inactivated by a tyrosine kinase. Anti-p34cdc2 can be used in western blotting, immunoprecipitation and immunohistochemistry.
The antibody precipitates an active kinase.
Specifications
| Manufacturer | Leinco Technologies Inc |
|---|---|
| Manufacturer Cat# | P316 |
| Concentration | 0.2 mg/ml |
| Formulation | This DyLight® 650 conjugate is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative. |
| Alternate Names | Monoclonal Antibody p34cdc2 Serine/Threonine Kinase 17 Human Anti-Human p34cdc2 Serine/Threonine Kinase - DyLight® 650 |
| Isotype | IgG2a |
| Clone | 17 |
| Target | p34cdc2 Serine/Threonine Kinase |
| Antibody Type | Monoclonal |
| Applications | FC |
| Storage | This DyLight® 650 conjugate is stable when stored at 2-8°C. Do not freeze. |
| Protein | p34cdc2 Serine/Threonine Kinase |